Touchstone International Medical Science’s IPO debut on SSE STAR Market today
Sep 28, 2020 (China Knowledge) - Touchstone International Medical Science (688013) to start trading on the Shanghai STAR Market today, at a public offering price of RMB 18.62 per share, raising RMB 372.4 mln. Its initial listing shares account for 25% of total outstanding shares. The company’s initial price-to-earning ratio (PE) stands at 38.21.
Essence Securities acted as the lead underwriter and sponsor for the IPO.
Earlier, Touchstone International Medical Science said its IPO was 3,497 times oversubscribed. Since 2019 to date, A-shares IPOs achieved median oversubscription of 2,373 times and the highest at 8,375 times. For subsequent 30-day trading the performances can be obtained from our China IPO Weekly.
Not Signed In
In financial year 2019, Touchstone International Medical Science garnered a total revenue of RMB 172.76 mln, up 45% YoY. In terms of net income, it achieved RMB 49 mln, up 79% YoY. Accordingly, return on equity (ROE) and return on asset (ROA) stood at 44.2% and 34.74% respectively, earning per share (EPS) of 0 RMB.
Copyright © 2018 www.chinaknowledge.com
Send feedback or comments to: email@example.com
For more news, financial weekly reports, business guides to China and other premium information, subscribe to China Knowledge today: www.chinaknowledge.com
To access our page on Bloomberg, type CKFI